MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 123 filers reported holding MACROGENICS INC in Q1 2020. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,864 | -12.9% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,140 | -25.4% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,868 | +6.9% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,684 | +168.4% | 400 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | -75.0% | 400 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $4,000 | -33.3% | 400 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $6,000 | -25.0% | 400 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $8,000 | -27.3% | 400 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $11,000 | -15.4% | 400 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $13,000 | +44.4% | 400 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $9,000 | -10.0% | 400 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $10,000 | -9.1% | 400 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $11,000 | +450.0% | 400 | 0.0% | 0.01% | +500.0% |
| Q1 2020 | $2,000 | -50.0% | 400 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,264,158 | $5,890,976 | 1.79% |
| Bellevue Group AG | 9,803,313 | $45,683,439 | 0.74% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $8,402,931 | 0.56% |
| DAFNA Capital Management LLC | 258,496 | $1,204,591 | 0.38% |
| SECTORAL ASSET MANAGEMENT INC | 387,001 | $1,803,425 | 0.35% |
| ARMISTICE CAPITAL, LLC | 4,712,000 | $21,957,920 | 0.34% |
| Rock Springs Capital Management LP | 1,178,796 | $5,493,189 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 225,918 | $1,053 | 0.09% |
| PINNACLE ASSOCIATES LTD | 697,067 | $3,248,332 | 0.06% |
| XTX Topco Ltd | 53,269 | $248,234 | 0.04% |